secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001193125-25-149104
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics stockholder votes: three Class III directors elected, auditor ratified
--------------------------------------------------------------------------------

- Howard Berman (5,821,649 for, 505,761 withheld), Arun Swaminathan (6,324,520 for, 2,890 withheld), Ann Lee (5,779,312 for, 548,098 withheld) elected as Class III directors.
- Ratification of Weaver and Tidwell as independent auditor approved: 10,355,085 for, 68,851 against, 340 abstentions.
- Broker non-votes of 4,096,866 were present for director election items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312525149104/0001193125-25-149104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312525149104/d60996d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-149104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer